GLP-1 pills represent a pivotal moment in obesity medicine and a significant leap forward in patient accessibility and treatment adherence
The brand source materials describe the full process from intake to medication-in-hand as approximately 2 to 3 weeks
You can read the abstract of this article at LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial PubMed (nih.gov)
External resources FDA: Concerns with unapproved GLP-1 drugs used for weight loss Obesity Action Coalition: Statement on grey market GLP-1 products National Association of Boards of Pharmacy: Verify your pharmacy In case I do not see you, good afternoon, good evening, and good night
While this offers little hard information on flux through the various steps, it is consistent with glutathione making a relatively small contribution to ascorbate regeneration, all the more so if GR also has to maintain GSH oxidized by DHA-independent processes